FindTrial
Sign In

Establishment and validation of key index quality targets of peripheral blood lymphocyte subsets by flow cytometry

Establishment and validation of key index quality targets of peripheral blood lymphocyte subsets by flow cytometry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112530
Enrollment
Unknown
Registered
2025-11-17
Start date
2024-04-15
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral blood lymphocyte subsets

Interventions

Blood routine test observation group:None

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients selected for blood routine tests were collected, including those with extremely low lymphocyte counts (lymphocytes 3.2 × 10^9/L).

Exclusion criteria

Exclusion criteria: Patients with a confirmed hematological tumor.

Design outcomes

Primary

MeasureTime frame
Enumeration of Peripheral Blood Lymphocyte Subsets (EPBLS);—

Countries

China

Contacts

Public ContactXiao Lin

Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

xiaolin5022@sina.com+86 10 8778 7503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026